This federal contract award is for the pharmaceutical product HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, awarded to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,223.43, is a delivery order issued by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract does not have a set-aside designation, indicating it was competitively awarded.
Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 that runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Generated 3/16/25, 12:56 AM